IBB vs RYLD
iShares Biotechnology ETF vs Global X Russell 2000 Covered Call ETF
- • IBB has the lower expense ratio at 0.44% vs 0.60% for RYLD.
- • RYLD pays a higher dividend yield (11.85%).
Side-by-side metrics
| Metric | IBB | RYLD |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.60% |
Dividend yield Trailing 12-month yield. | 0.23% | 11.85% |
AUM Assets under management — bigger funds are typically more liquid. | $7.95B | $1.32B |
YTD return | 3.10% | 6.49% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.74 | 0.55 |
P/E ratio | 23.72 | 19.20 |
Last price | $170.10 | $15.61 |
Inception | — | — |
Issuer | iShares | Global X |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
RYLD top holdings
| RSSL | Global X Russell 2000 ETF | 101.94% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About RYLD
RYLD (Global X Russell 2000 Covered Call ETF) is Russell 2000 covered call strategy for income. Managed by Global X, the fund carries $1.3B in assets under management, an expense ratio of 0.60%, a dividend yield of 11.85%. Its largest holding is Global X Russell 2000 ETF (RSSL), which represents 101.9% of the portfolio. Real Estate is the fund's largest sector exposure at 6.2%.